Join Alex Lorestani (CEO, Geltor) to discuss how and why brands and manufacturers serving the $500B global beauty market are increasingly turning to biology for solutions, and what that could mean for the future. While the promise of biotechnology has been speculated upon for applications in pharmaceuticals, agriculture, and nutrition, its foothold in beauty and personal care has been quietly gaining strength. The beauty industry has long been an early adopter of advancements in science and technology, and 21st century biodesign has turned out to be no exception – even in the midst of a global pandemic.